Rafferty Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $641K | Sell |
98,691
-20,469
| -17% | -$133K | ﹤0.01% | 838 |
|
|
2025
Q1 | $945K | Sell |
119,160
-40,248
| -25% | -$319K | ﹤0.01% | 754 |
|
|
2024
Q4 | $2.02M | Buy |
159,408
+22,975
| +17% | +$291K | 0.01% | 646 |
|
|
2024
Q3 | $1.9M | Sell |
136,433
-13,222
| -9% | -$184K | 0.01% | 650 |
|
|
2024
Q2 | $2.06M | Sell |
149,655
-43,569
| -23% | -$600K | 0.01% | 630 |
|
|
2024
Q1 | $3.19M | Sell |
193,224
-43,123
| -18% | -$712K | 0.01% | 562 |
|
|
2023
Q4 | $3.45M | Sell |
236,347
-737
| -0.3% | -$10.8K | 0.01% | 521 |
|
|
2023
Q3 | $2.91M | Sell |
237,084
-53,924
| -19% | -$662K | 0.02% | 504 |
|
|
2023
Q2 | $3.47M | Buy |
291,008
+99,563
| +52% | +$1.19M | 0.02% | 495 |
|
|
2023
Q1 | $2.56M | Sell |
191,445
-14,001
| -7% | -$187K | 0.02% | 538 |
|
|
2022
Q4 | $4.42M | Buy |
205,446
+60,812
| +42% | +$1.31M | 0.04% | 402 |
|
|
2022
Q3 | $2.9M | Buy |
+144,634
| New | +$2.9M | 0.03% | 425 |
|